STOCK TITAN
  1. Home
  2. Sec-filings
  3. VTVT
  4. [EFFECT] vTv Therapeutics Inc. SEC Filing

[EFFECT] vTv Therapeutics Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 24, 2025 4:00 P.M.
Form: S-3
CIK: 0001641489
Company Name: vTv Therapeutics Inc.
File Number: 333-290709

Source: View Original Filing on SEC EDGAR

Stock VTVT logo
Vtv Therapeutics

NASDAQ:VTVT

VTVT Rankings

#4776 Ranked by Market Cap
N/A Ranked by Dividends

VTVT Latest News

Feb 13, 2026
vTv Therapeutics to Participate in Upcoming Investor Conferences
Feb 2, 2026
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
Dec 18, 2025
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
Nov 6, 2025
vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Oct 9, 2025
vTv Therapeutics Announces New Appointments to its Scientific Advisory Board

VTVT Latest SEC Filings

Feb 26, 2026
[8-K] vTv Therapeutics Inc. Reports Material Event
Feb 18, 2026
[Form 4] vTv Therapeutics Inc. Insider Trading Activity
Feb 18, 2026
[Form 4] vTv Therapeutics Inc. Insider Trading Activity
Feb 2, 2026
[8-K] vTv Therapeutics Inc. Reports Material Event
Nov 6, 2025
[8-K] vTv Therapeutics Inc. Reports Material Event

VTVT Stock Data

146.57M
3.01M
Biotechnology
Pharmaceutical Preparations
Link
United States
HIGH POINT